Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3220 results found

2024 ∙ Shabani, M. Shobeiri, P. Nouri, S. Moradi, Z. Amenu, R. A. Mehrabi Nejad, M. M. Rezaei, N.

Risk of flare or relapse in patients with immune-mediated diseases following SARS-CoV-2 vaccination: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Bianchi, F. P. Polignano, M. Carella, N. Rotolo, O. Curlo, M. Mastronardi, M.

Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Zhuo, Y. Lu, Z. Zhang, X. Yang, Y. Han, J. Du, J. Xu, Y. Liu, Y. Fu, C.

Rubella antibody levels in the healthy Chinese population: a meta-analysis

  • Western Pacific
  • China
  • All age groups
  • Rubella
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Seyedalinaghi, S. Pashaei, A. Tantuoyir, M. M. Karimi, A. Mojdeganlou, H. Nazarian, N. Vahedi, F. Afzalian, A. Shobeiri, P. Dashti, M. Ghasemzadeh, A. Mirzapour, P. Parikhani, S. N. Mehraeen, E.

Safety and Adverse Effects Related to COVID-19 Viral Vector Vaccines: A Systematic Review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Ciapponi, A. Berrueta, M. Argento, F. J. Ballivian, J. Bardach, A. Brizuela, M. E. Castellana, N. Comandé, D. Gottlieb, S. Kampmann, B. Mazzoni, A. Parker, E. P. K. Sambade, J. M. Stegelmann, K. Xiong, X. Stergachis, A. Buekens, P.

Safety and Effectiveness of COVID-19 Vaccines During Pregnancy: A Living Systematic Review and Meta-analysis

  • Pregnant women
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Beladiya, J. Kumar, A. Vasava, Y. Parmar, K. Patel, D. Patel, S. Dholakia, S. Sheth, D. Boddu, S. H. S. Patel, C.

Safety and efficacy of COVID-19 vaccines: A systematic review and meta-analysis of controlled and randomized clinical trials

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Xiao, G. He, T. Zhang, B. Yang, Z. Ling, N. Chen, M. Zhang, D. Hu, P. Zhang, G. Peng, M. Cai, D. Ren, H.

Safety and Efficacy of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Pang, Y. Cao, D. Zhu, X. Long, Q. Tian, F. Long, X. Li, Y.

Safety and Efficacy of the Modified Vaccinia Ankara-Bavaria Nordic Vaccine Against Mpox in the Real World: Systematic Review and Meta-Analysis

  • All age groups
  • Mpox
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Santangelo, O. E. Provenzano, S. Vella, C. Fermi, S. Facchini, L. Rizzo, M. Brighina, F. Cedrone, F. Firenze, A.

Safety and efficacy of vaccinations in patients with multiple sclerosis: a systematic review

  • All age groups
  • COVID-19
  • Influenza
  • Measles
  • Mumps
  • Rubella
  • Yellow fever
  • Varicella
  • Tetanus
  • Tick-borne encephalitis
  • Diphtheria
  • Pertussis
  • Meningococcal disease
  • Pneumococcal disease
  • Rabies
  • Haemophilus influenzae type B
  • Hepatitis B
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Mohamed Taha, A. Abouelmagd, K. Mahmoud, A. M. Elkasaby, M. H. Nguyen, D. Ahmed, R. Patel, P. Bonilla-Aldana, D. K. Luna, C. Rodriguez-Morales, A. J.

Safety and immunogenicity of Vi-diphtheria toxoid typhoid conjugate vaccine among children below 2 years: a systematic review and meta-analysis

  • Newborn
  • Children
  • Typhoid
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...